90
Participants
Start Date
July 31, 2005
Primary Completion Date
March 31, 2008
Study Completion Date
April 30, 2008
Melperone HCl
20 mg/day. Strength of melperone syrup is 5 mg/mL
Melperone HCl
40 mg/day. Strength of melperone syrup is 5 mg/mL
Melperone HCl
60 mg/day. Strength of melperone syrup is 5 mg/mL
Placebo
Syrup formulation
Neurology Consultants of the Carolinas, Charlotte
University of South Florida, Tampa
Bradenton Research Center, Inc, Bradenton
University of Cincinnati Medical Center, Cincinnati
Quest Research Institute, Bingham Farms
Struthers Parkinson's Center, Park Nicollet Health Services, Golden Valley
Washington University School of Medicine, St Louis
Fondazione Universita di Chieti C.E.S.I. Centro Studi sull'Invecchiamento, Chieti Scalo
The University of Kansas Medical Center, Kansas City
Neurology Associates, San Antonio
Northwest Neurospecialists, PLLC, Tucson
"IRCCS Centro Neurolesi Bonino Pulejo", Messina
Department of Neurology, Manipal Hospital, Bangalore
M. S. Ramasah Memorial Hospital, Bangalore
Department of Neurology, Rajendra Prasad Ward, King George Hospital, Visakhapatnam, Visakhapatnam
KLE Hospital, Belgaum, Belagavi
Kasturra Medical College, Hospital, Attavar, Mangalore
SCTIMST, Trivandrum
Jaslok Hospital and Research Center, Mumbai
Apollo Hospitals Educational and Research Foundation, Chennai
U.O. Neurologia IRCCS San Raffaele Pisana, Rome
Lead Sponsor
Lundbeck LLC
INDUSTRY